The Centers for Medicare and Medicaid Services signaled in a Wednesday statement that it will continue the Inflation Reduction Act’s Medicare Part D drug price negotiations.
Trump Administration Signals Support for IRA Drug Price Negotiations
The Trump Administration indicated Wednesday that it will continue the Inflation Reduction Act’s (IRA) Medicare drug price negotiations, a signature [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.